MammoSite multilumen catheter: dosimetry considerations

Area of Science:

• Radiation Oncology
• Medical Physics
• Breast Surgery

Background:

• Accelerated partial breast irradiation (APBI) is an option for early-stage breast cancer.
• Brachytherapy delivers radiation from within the breast.
• The MammoSite balloon is a common brachytherapy device.

Purpose of the Study:

• To compare the dosimetric performance of the MammoSite multilumen (ML) balloon versus the single lumen (SL) device.
• To evaluate dose distribution and coverage for breast brachytherapy planning.

Main Methods:

• Two treatment plans were created for each patient using the MammoSite ML balloon.
• The first plan (SL) utilized only the central lumen.
• The second plan (ML) incorporated additional lumens for dose optimization.

Main Results:

• The ML plan demonstrated improved dose coverage at the applicator tip and base.
• Reduced skin and rib doses were observed with the ML plan when these structures were within 7 mm (skin) and 1 cm (rib) of the target.
• No significant dose reduction to normal structures was noted when distances were greater than 1 cm.

Conclusions:

• The MammoSite ML balloon can achieve better dosimetric goals in APBI.
• Optimal dose delivery is enhanced when critical structures like skin and ribs are in close proximity to the target volume.
• The ML device has the potential to minimize long-term toxicities such as rib discomfort and skin/fat necrosis.